By all accounts, 2019 was a year of continued robust healthcare M&A activity by private equity firms, significantly outpacing 2018. Private equity firms continued to deploy significant capital broadly across the healthcare industry during 2019 as demands to solve for industry inefficiencies, value-based payment models, and overall cost reduction all point toward private equity investment as an attractive option for healthcare businesses with aggressive growth strategies. In addition to the sustaining performance of the U.S. economy as a whole in 2019, the changing reimbursement and regulatory landscape of the healthcare industry contributed to deal volume overall and in particular sectors.
